UCSF, Mount Sinai and the Pasteur Institute unveil their first results in vitro for drug repositioning against COVID19 in Nature

2

French-American collaboration continues in the fight against COVID19. The international alliance formed by the University of California in San Francisco, the Mount Sinai Hospital in New York and the Institut Pasteur in Paris unveiled today the first results of its in vitro experiments on drug repositioning, a strategy that can lead to a rapid deployment of drugs that already exist against the epidemic.

Read the press release here.

Consult the article published in Nature here.

To support this collaboration, visit this page.

To find out more about this collaboration:

Interview with Nevan Krogan (QBI-UCSF) and the Consul General of France in San Francisco:

Partager

Derniers articles dans la thématique

|

France and US-based researchers and physicians discuss clinical trials in gene therapy at University of California, San Diego

| | |

November 2022, San Diego || FAIDs – Clinical Trials in Gene Therapy

| |

How can Southern California biotechnologies help the environment?

Deadline, April 15 to apply to the master degree’s BioTechEco

|

COVID-19 – Conversation can play an important role in the asymptomatic spreading of virus

Emmanuelle Charpentier receives the Nobel Prize in Chemistry 2020

|

Science is here !

MASTER – Computational Neuroscience and Neuroengineering.

| |

CORD19 Publications Dashboard

The 2nd ICPerMed Conference ’Personalised Medicine – From Vision to Practice’

For the first time a patient benefits from a unique gene therapy to treat cystinosis, developed by Cherqui’s laboratory at UC San Diego

Office for Science and Technology

Associated Research Organizations

Useful links

Ambassade de France

France Diplomatie

EURAXESS North America

D-FI USA

Twitter Linkedin

Legal Notice – Privacy Policy

© Copyright 2023 – Office for Science and Technology. All rights reserved